The life-sciences and chemical group said it now expects 2024 net sales in the lower half of its previously expected range of ...

German sci-tech giant Merck is very optimistic about its prospects in the Chinese market and will continue to strengthen its ...

FRANKFURT, Nov 14 (Reuters) - Merck KGaA (MRCG.DE), opens new tab on Thursday reported a gain of 11.9% in adjusted quarterly ...

The life-sciences and chemical group said it now expects 2024 net sales in the lower half of its previously expected range of ...

(Bloomberg) -- Merck KGaA posted earnings that topped estimates as its ... That’s better than the €1.56 billion average of ...

Merck has signed a licensing agreement worth up to $3.3 billion with Shanghai-based LaNova Medicines to develop, make and ...

Driven by growth across the board, including in its semiconductor business, German science and technology company Merck ...

German companies including Merck and ZEISS expressed strong confidence and high hopes for the Chinese market at the China ...

Merck KGaA (MKGAY.PK), a German science and technology major, announced that the Phase III MANEUVER trial of pimicotinib, an ...

Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that the Phase III MANEUVER trial ...

Germany's cabinet on Wednesday approved plans to require most operators of new wind and solar power plants to sell their ...